Ocumetra aims to deliver innovative myopia care solutions and vital decision support to practitioners in the rapidly changing field of myopia control. This includes our Communication Tools (mEYE Guide) which can help clinicians to streamline the difficult and long conversation with their patients parents by generating an easy to understand shareable report designed specifically for parents. This helps to convert a long conversation into a short and effective one, saving chair time and helping parents make an informed decision in relation to myopia control. We are also developing a platform of Clinical Decision Support Tools (Refractive Mechanism Map and the Refractogram) which will comprise of clinically relevant features including interactive ocular growth charts, myopia treatment efficacy analytics and other clinical decision support tools.
Ocumetra is university based company, a spin-out from the Technological University of Dublin, that was co-founded by Ian Flitcroft and James Loughman, who are working together on their shared passion for all things myopia. With more than €10 million research funding, over 120 scientific papers published, countless lectures delivered and numerous clinical trials ongoing, understanding myopia and delivering ways to get it under control represents the core focus of their work.
mEYE™ Guide is a communication tool created to help clinicians streamline the difficult and long conversation with their patients parents by generating an easy to understand shareable report designed specifically for parents.
A. Ocumetra is a data analytics company whose goal is to support eye care practitioners in providing high quality, evidence-based myopia management to all their patients. Ocumetra was founded by two globally renowned researchers and clinicians, Professor James Loughman PhD and Professor Ian Flitcroft D.Phil FRCOphth. With more than 150 scientific papers published, countless lectures delivered and numerous clinical trials ongoing, understanding myopia and delivering ways to get it under control represents the core focus of their work.
We provide patient communication, clinical decision support and business intelligence solutions to ECPs and industry clients. Our patient communication tools are designed to promote better uptake and retention of myopia management treatments. We have developed a unique portfolio of tools to help you communicate and explain the rationale and options of myopia management to their patients as well as monitoring efficacy. We provide the answers you need to deliver personalised, adaptive eye care to every myopia patient.
A. mEYE™ Guide is a monthly subscription service (€49.99/mo.; $54.99/mo.; £44.99/mo.) with a 2-week free trial. To celebrate the launch of mEYE™ Guide we are also giving you free access to mEYE™ Gauge, which allows you to begin to integrate axial length into your myopia management routine without the significant expense of a biometry device.
A. You will enter your payment details to activate your free trial so once your free trial expires you will begin paying for the platform. We will remind you when your trial is about to expire.
A. mEYE™ Guide can be used on any device (phone, tablet, or desktop) as it’s a web-based tool that’s accessed from all modern browsers.
A. mEYE™ Guide is currently available in English-only. We will be expanding the platform to cover additional languages soon. If you have any questions regarding the multi-lingual platform, please contact us at email@example.com.
A. Yes, Ocumetra is committed to ensuring protection of all personal information that we hold, and to provide and to protect all such data. All our products are designed to meet the requirements of GDPR. Ocumetra is ISO Certified for our Information Security Management System (ISO27001 Certified).
A. This is something we are already working on. If you have an inquiry about a particular practice software please get in touch with us at firstname.lastname@example.org.
All-in-access to Ocumetra pro will cost as little as 50 cent/pence per day. So the real question is, can you afford not to have it in your practice. Check out our full pricing schedule for your region here
Hold on tight, it's coming soon. In the meantime, please visit our Sign up page if you'd like to get notified when it launches.
Of course, and we have his centile chart details too!